John M. Hudson

Dynamic microbubble contrast-enhanced US to measure tumor response to targeted therapy: a proposed clinical protocol with results from renal cell carcinoma patients receiving antiangiogenic therapy.

Peter N. Burns, Mostafa Atri, Laurent Milot, 2011, Radiology.

The prognostic and predictive value of vascular response parameters measured by dynamic contrast-enhanced-CT, -MRI and -US in patients with metastatic renal cell carcinoma receiving sunitinib

Peter N. Burns, Greg Stanisz, Mostafa Atri, 2018, European Radiology.

Imaging innovations for cancer therapy response monitoring

Martin J. Yaffe, Gregory J. Czarnota, Michael C. Kolios, 2012 .